These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27006371)

  • 1. Comparison of 68Ga-DOTANOC PET/CT and contrast-enhanced CT in localisation of tumours in ectopic ACTH syndrome.
    Goroshi MR; Jadhav SS; Lila AR; Kasaliwal R; Khare S; Yerawar CG; Hira P; Phadke U; Shah H; Lele VR; Malhotra G; Bandgar T; Shah NS
    Endocr Connect; 2016 Mar; 5(2):83-91. PubMed ID: 27006371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of diagnostic efficacy of
    Zhang B; He Q; Long Y; Zhang Y; Wang X; Chen Z; Liu J; Zhang X
    Front Endocrinol (Lausanne); 2022; 13():962800. PubMed ID: 36213295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Contrast-Enhanced CT + CT Enterography and 68Ga-DOTANOC PET/CT in Gastroenteropancreatic Neuroendocrine Tumors.
    Sharma A; Das CJ; Makharia GK; Arora G; Kumar R
    Clin Nucl Med; 2020 Nov; 45(11):848-853. PubMed ID: 32657875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic performance of somatostatin receptor PET/CT using 68Ga-DOTANOC in gastrinoma patients with negative or equivocal CT findings.
    Naswa N; Sharma P; Soundararajan R; Karunanithi S; Nazar AH; Kumar R; Malhotra A; Bal C
    Abdom Imaging; 2013 Jun; 38(3):552-60. PubMed ID: 22743840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic utility of Gallium-68-somatostatin receptor PET/CT in ectopic ACTH-secreting tumors: a systematic literature review and single-center clinical experience.
    Varlamov E; Hinojosa-Amaya JM; Stack M; Fleseriu M
    Pituitary; 2019 Oct; 22(5):445-455. PubMed ID: 31236798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance of various imaging modalities in localizing ectopic ACTH syndrome: A systematic review.
    Channaiah CY; Memon SS; Lila AR; Sarathi V; Karlekar M; Barnabas R; Patil VA; Sharma A; Phadte A; Malhotra G; Shah N; Bandgar T
    Ann Endocrinol (Paris); 2024 Dec; 85(6):596-603. PubMed ID: 39002895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic values of
    Kumar R; Vankadari K; Mittal BR; Bansal D; Trehan A; Sahu JK; Sankhyan N
    Eur Radiol; 2021 Jul; 31(7):4587-4594. PubMed ID: 33409780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ga-68 DOTANOC PET/CT imaging in detection of primary site in patients with metastatic neuroendocrine tumours of unknown origin and its impact on clinical decision making: experience from a tertiary care centre in India.
    Pruthi A; Pankaj P; Verma R; Jain A; Belho ES; Mahajan H
    J Gastrointest Oncol; 2016 Jun; 7(3):449-61. PubMed ID: 27284479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of 68Ga-DOTA derivatives PET-CT in patients with ectopic ACTH syndrome.
    Ceccato F; Cecchin D; Gregianin M; Ricci G; Campi C; Crimì F; Bergamo M; Versari A; Lacognata C; Rea F; Barbot M; Scaroni C
    Endocr Connect; 2020 Apr; 9(4):337-345. PubMed ID: 32213660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic efficiency of
    He Q; Zhang B; Zhang L; Chen Z; Shi X; Yi C; Wang X; Zhang X
    Eur Radiol; 2021 Apr; 31(4):2414-2421. PubMed ID: 33021702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 68Ga-DOTANOC PET/CT for baseline evaluation of patients with head and neck paraganglioma.
    Sharma P; Thakar A; Suman K C S; Dhull VS; Singh H; Naswa N; Reddy RM; Karunanithi S; Kumar R; Kumar R; Malhotra A; Bal C
    J Nucl Med; 2013 Jun; 54(6):841-7. PubMed ID: 23520216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical value of ⁶⁸Ga-DOTATATE-PET/CT compared to stand-alone contrast enhanced CT for the detection of extra-hepatic metastases in patients with neuroendocrine tumours (NET).
    Albanus DR; Apitzsch J; Erdem Z; Erdem O; Verburg FA; Behrendt FF; Mottaghy FM; Heinzel A
    Eur J Radiol; 2015 Oct; 84(10):1866-72. PubMed ID: 26152870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.
    Wild D; Bomanji JB; Benkert P; Maecke H; Ell PJ; Reubi JC; Caplin ME
    J Nucl Med; 2013 Mar; 54(3):364-72. PubMed ID: 23297077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin receptor based PET/CT imaging with 68Ga-DOTA-Nal3-octreotide for localization of clinically and biochemically suspected insulinoma.
    Sharma P; Arora S; Karunanithi S; Khadgawat R; Durgapal P; Sharma R; Kandasamy D; Bal C; Kumar R
    Q J Nucl Med Mol Imaging; 2016 Mar; 60(1):69-76. PubMed ID: 24740163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin receptor expression in lymphomas: a source of false diagnosis of neuroendocrine tumor at
    Ruuska T; Ramírez Escalante Y; Vaittinen S; Gardberg M; Kiviniemi A; Marjamäki P; Kemppainen J; Jyrkkiö S; Minn H
    Acta Oncol; 2018 Feb; 57(2):283-289. PubMed ID: 28686510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of 68Ga-DOTANOC PET/CT in patients with suspicion of neuroendocrine tumors: is its routine use justified?
    Sharma P; Arora S; Mukherjee A; Pal S; Sahni P; Garg P; Khadgawat R; Thulkar S; Bal C; Kumar R
    Clin Nucl Med; 2014 Jan; 39(1):37-43. PubMed ID: 24152621
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Souteiro P; Gouveia P; Ferreira G; Belo S; Costa C; Carvalho D; Duarte H; Sampaio IL
    Endocrine; 2019 May; 64(2):322-329. PubMed ID: 30684230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-Body 68Ga-DOTANOC PET/MRI Versus 68Ga-DOTANOC PET/CT in Patients With Neuroendocrine Tumors: A Prospective Study in 28 Patients.
    Berzaczy D; Giraudo C; Haug AR; Raderer M; Senn D; Karanikas G; Weber M; Mayerhoefer ME
    Clin Nucl Med; 2017 Sep; 42(9):669-674. PubMed ID: 28682844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 68Ga-DOTANOC PET/CT clinical impact in patients with neuroendocrine tumors.
    Ambrosini V; Campana D; Bodei L; Nanni C; Castellucci P; Allegri V; Montini GC; Tomassetti P; Paganelli G; Fanti S
    J Nucl Med; 2010 May; 51(5):669-73. PubMed ID: 20395323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [68Ga]Ga-DOTANOC Uptake at Pancreatic Head/Uncinate Process: Is It a Persistent Diagnostic Pitfall Over Time?
    Tabacchi E; Fortunati E; Argalia G; Zanoni L; Calabrò D; Telo S; Campana D; Lamberti G; Ricci C; Casadei R; Fanti S; Ambrosini V
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.